The Northwestern Medicine Chicago Proton Center will host over 200 leading clinicians, physicists and researchers in the growing field of proton therapy at the 4th...
Athens, Ga. -- A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven...
Credit: Courtesy of Albert Einstein College of Medicne October 19, 2017--(Bronx, NY)--In a study in today's issue of Science, researchers at Albert Einstein College of...
Credit: Indiana University BLOOMINGTON, Ind. -- The number of newly diagnosed cancer patients who were uninsured fell by one-third in the first year of the...
CAMBRIDGE, MA -- Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs...
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than...
Sylentis, a Pharmaceutical Company of PharmaMar Group (MCE: PHM), pioneer in the development of new compounds based on genetic silencing technology through RNA interference (RNAi),...
Cambridge, MA October 19, 2017. - A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate...
A new research letter published by JAMA Oncology examines changes in insurance coverage among patients with cancer under the Affordable Care Act. Aparna Soni, M.A.,...
SALT LAKE CITY - The results of a national cancer survey find a significant number of childhood cancer survivors are worried about keeping their health...
A new study published in Nature, conducted by an alliance between industry and academia involving the University of Liverpool, highlights a new approach to targeting...
Credit: Parag Parikh, M.D., Associate Professor of Radiation Oncology and Biomedical Engineering at Washington University in St. Louis ViewRay, Inc. (Nasdaq: VRAY), maker of the...
Credit: Penn Medicine PHILADELPHIA - Imagine trying to take a picture of a runner, but only being able to see her feet. If you could...
Credit: The University of Chicago Medicine The U.S. Food and Drug Administration today approved the use of a breakthrough cancer treatment -- Yescarta (axicabtagene ciloleucel)...
Credit: UC San Diego A human gene called p53, which is commonly known as the "guardian of the genome," is widely known to combat the...
